What it said it expected, against what it reported
6 targets with a reported result
Above the range
2
above the last range given
Within the range
4
of 6 range targets
Below the range
0
below the last range given
The numbers HCA said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from
| Target | What the company said | Reported | Result |
|---|---|---|---|
| EBITDA (company-defined) Fiscal 2026 |
Given $15.55B to $16.45B release 2026-01-27
Lowered $15.40B to $16.10B release 2026-07-14
Kept $15.40B to $16.10B release 2026-07-24
|
– | No standard number |
The company's words2026 Guidance Range … Adjusted EBITDA $15.550 to $16.450 billion release 2026-01-27 Previous 2026 Guidance Revised 2026 Guidance Ranges, Ranges, as of July 14, as of January 27, 2026 2026 … Adjusted EBITDA billion $15.400 to $16.100 billion release 2026-07-14 Previous 2026 Guidance Revised 2026 Guidance Ranges, Ranges, as of July 14, as of January 27, 2026 2026 … Adjusted EBITDA billion $15.400 to $16.100 billion release 2026-07-24 | |||
| Capital expenditures (company-defined) Fiscal 2026 |
Given $5.00B to $5.50B release 2026-01-27
|
– | No standard number |
The company's wordsCapital expenditures for 2026, excluding acquisitions, are estimated to range between $5.0 billion and $5.5 billion. release 2026-01-27 | |||
| Capital expenditures Fiscal 2026 |
Given $5.00B to $5.50B release 2026-07-14
Kept $5.00B to $5.50B release 2026-07-24
|
– | Not reported yet |
The company's wordsThe Company will provide additional commentary on its second quarter earnings call. 2026 Updated Guidance and Key Assumptions Based on results through the first half of the year, the Company has revised its 2026 guidance as follows: … The Company's 2026 estimate for capital expenditures of $5.0 billion to $5.5 billion, excluding acquisitions, remains unchanged. release 2026-07-14 Future dividends are expected to be funded by cash balances and future cash flows from operations. 2026 Updated Guidance and Key Assumptions Based on results through the first half of the year, the Company has revised its 2026 guidance as follows: … The Company's 2026 estimate for capital expenditures of $5.0 billion to $5.5 billion, excluding acquisitions, remains unchanged. release 2026-07-24 | |||
| Net income Fiscal 2026 |
Given $6.50B to $7.04B release 2026-01-27
Lowered $6.30B to $6.70B release 2026-07-14
Kept $6.30B to $6.70B release 2026-07-24
|
– | Not reported yet |
The company's words2026 Guidance Range … Net Income Attributable to HCA $6.495 to $7.035 billion release 2026-01-27 Previous 2026 Guidance Revised 2026 Guidance Ranges, Ranges, as of July 14, as of January 27, 2026 2026 … Net Income Attributable to HCA $6.300 to $6.700 billion release 2026-07-14 Previous 2026 Guidance Revised 2026 Guidance Ranges, Ranges, as of July 14, as of January 27, 2026 2026 … Net Income Attributable to HCA $6.300 to $6.700 billion release 2026-07-24 | |||
| Diluted EPS Fiscal 2026 |
Given $29.10 to $31.50 release 2026-01-27
Lowered $28.70 to $30.50 release 2026-07-14
Kept $28.70 to $30.50 release 2026-07-24
|
– | Not reported yet |
The company's words2026 Guidance Range … EPS (diluted) $29.10 to $31.50 release 2026-01-27 Previous 2026 Guidance Revised 2026 Guidance Ranges, Ranges, as of July 14, as of January 27, 2026 2026 … EPS (diluted) $28.70 to $30.50 release 2026-07-14 Previous 2026 Guidance Revised 2026 Guidance Ranges, Ranges, as of July 14, as of January 27, 2026 2026 … EPS (diluted) $28.70 to $30.50 release 2026-07-24 | |||
| Revenue Fiscal 2026 |
Given $76.50B to $80.00B release 2026-01-27
Narrowed $77.00B to $79.50B release 2026-07-14
Kept $77.00B to $79.50B release 2026-07-24
|
– | Not reported yet |
The company's words2026 Guidance Range … Revenues $76.500 to $80.000 billion release 2026-01-27 Previous 2026 Guidance Revised 2026 Guidance Ranges, Ranges, as of July 14, as of January 27, 2026 2026 … Revenues billion $77.000 to $79.500 billion release 2026-07-14 Previous 2026 Guidance Revised 2026 Guidance Ranges, Ranges, as of July 14, as of January 27, 2026 2026 … Revenues billion $77.000 to $79.500 billion release 2026-07-24 | |||
| EBITDA (company-defined) Fiscal 2025 (ended 2025-12-31) |
Given $14.30B to $15.10B release 2025-01-24
Raised $14.70B to $15.30B release 2025-07-25
Raised $15.25B to $15.65B release 2025-10-24
|
– | No standard number |
The company's words2025 Guidance Range … Adjusted EBITDA $14.30 to $15.10 billion release 2025-01-24 Previous 2025 Guidance Revised 2025 Guidance Range, as Range, of January 24, 2025 as of July 25, 2025 … Adjusted EBITDA $14.70 to $15.30 billion release 2025-07-25 Previous 2025 Guidance Revised 2025 Guidance Range, Range, as as of July 25, 2025 of October 24, 2025 … Adjusted EBITDA billion $15.250 to $15.650 billion release 2025-10-24 | |||
| Capital expenditures (company-defined) Fiscal 2025 (ended 2025-12-31) |
Given $5.00B to $5.20B release 2025-01-24
|
– | No standard number |
The company's wordsAll facilities impacted by Hurricanes Helene and Milton have resumed normal operations. 2025 Guidance Today, the Company issued the following estimated guidance for 2025: … Capital expenditures for 2025, excluding acquisitions, are estimated to be approximately $5.0 to $5.2 billion. release 2025-01-24 | |||
| Net income Fiscal 2025 (ended 2025-12-31) |
Given $5.85B to $6.29B release 2025-01-24
Raised $6.11B to $6.48B release 2025-07-25
Raised $6.50B to $6.71B release 2025-10-24
|
$6.78B 10-K filed 2026-02-10 |
Above the range |
The company's words2025 Guidance Range … Net Income Attributable to HCA $5.85 to $6.29 billion release 2025-01-24 Previous 2025 Guidance Revised 2025 Guidance Range, as Range, of January 24, 2025 as of July 25, 2025 … Net Income Attributable to HCA $6.11 to $6.48 billion release 2025-07-25 Previous 2025 Guidance Revised 2025 Guidance Range, Range, as as of July 25, 2025 of October 24, 2025 … Net Income Attributable to HCA $6.495 to $6.715 billion release 2025-10-24 | |||
| Diluted EPS Fiscal 2025 (ended 2025-12-31) |
Given $24.05 to $25.85 release 2025-01-24
Raised $25.50 to $27.00 release 2025-07-25
Raised $27.00 to $28.00 release 2025-10-24
|
$28.33 10-K filed 2026-02-10 |
Above the range |
The company's words2025 Guidance Range … EPS (diluted) $24.05 to $25.85 release 2025-01-24 Previous 2025 Guidance Revised 2025 Guidance Range, as Range, of January 24, 2025 as of July 25, 2025 … EPS (diluted) $25.50 to $27.00 release 2025-07-25 Previous 2025 Guidance Revised 2025 Guidance Range, Range, as as of July 25, 2025 of October 24, 2025 … EPS (diluted) $27.00 to $28.00 release 2025-10-24 | |||
| Revenue Fiscal 2025 (ended 2025-12-31) |
Given $72.80B to $75.80B release 2025-01-24
Raised $74.00B to $76.00B release 2025-07-25
Raised $75.00B to $76.50B release 2025-10-24
|
$75.60B 10-K filed 2026-02-10 |
Within the range |
The company's words2025 Guidance Range … Revenues $72.80 to $75.80 billion release 2025-01-24 Previous 2025 Guidance Revised 2025 Guidance Range, as Range, of January 24, 2025 as of July 25, 2025 … Revenues $74.00 to $76.00 billion release 2025-07-25 Previous 2025 Guidance Revised 2025 Guidance Range, Range, as as of July 25, 2025 of October 24, 2025 … Revenues billion $75.000 to $76.500 billion release 2025-10-24 | |||
| EBITDA (company-defined) Fiscal 2024 (ended 2024-12-31) |
Given $12.85B to $13.55B release 2024-01-30
Raised $13.75B to $14.25B release 2024-07-23
|
– | No standard number |
The company's words2024 Guidance Range … Adjusted EBITDA $12.85 to $13.55 billion release 2024-01-30 Previous 2024 Guidance Revised 2024 Guidance Range Range as of January 30, 2024 as of July 23, 2024 … Adjusted EBITDA billion $13.750 to $14.250 billion release 2024-07-23 | |||
| Capital expenditures (company-defined) Fiscal 2024 (ended 2024-12-31) |
Given $5.10B to $5.30B release 2024-01-30
Kept $5.10B to $5.30B release 2024-07-23
|
– | No standard number |
The company's wordsCapital expenditures for 2024, excluding acquisitions, are estimated to be in the range of $5.1 to $5.3 billion. release 2024-01-30 Capital expenditures for 2024, excluding acquisitions, are estimated to be in the range of $5.1 to $5.3 billion. release 2024-07-23 | |||
| Net income Fiscal 2024 (ended 2024-12-31) |
Given $5.20B to $5.60B release 2024-01-30
Raised $5.67B to $5.97B release 2024-07-23
|
$5.76B 10-K filed 2025-02-14 |
Within the range |
The company's words2024 Guidance Range … Net Income Attributable to HCA $5.20 to $5.60 billion release 2024-01-30 Previous 2024 Guidance Revised 2024 Guidance Range Range as of January 30, 2024 as of July 23, 2024 … Net Income Attributable to HCA billion $5.675 to $5.975 billion release 2024-07-23 | |||
| Diluted EPS Fiscal 2024 (ended 2024-12-31) |
Given $19.70 to $21.20 release 2024-01-30
Raised $21.60 to $22.80 release 2024-07-23
|
$22.00 10-K filed 2025-02-14 |
Within the range |
The company's words2024 Guidance Range … EPS (diluted) $19.70 to $21.20 release 2024-01-30 Previous 2024 Guidance Revised 2024 Guidance Range Range as of January 30, 2024 as of July 23, 2024 … EPS (diluted) $21.60 to $22.80 release 2024-07-23 | |||
| Revenue Fiscal 2024 (ended 2024-12-31) |
Given $67.75B to $70.25B release 2024-01-30
Raised $69.75B to $71.75B release 2024-07-23
|
$70.60B 10-K filed 2025-02-14 |
Within the range |
The company's words2024 Guidance Range … Revenues $67.75 to $70.25 billion release 2024-01-30 Previous 2024 Guidance Revised 2024 Guidance Range Range as of January 30, 2024 as of July 23, 2024 … Revenues billion $69.750 to $71.750 billion release 2024-07-23 | |||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (13 releases since 2024-01-30), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.